应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
NVO 诺和诺德
交易中 09-25 11:25:17 EDT
38.61
-0.01
-0.03%
最高
38.83
最低
38.41
成交量
388.48万
今开
38.81
昨收
38.62
日振幅
1.09%
总市值
1,724亿
流通市值
1,231亿
总股本
44.65亿
成交额
1.50亿
换手率
0.12%
流通股本
31.88亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
诺和押注下一发展篇章，礼来在GLP‑1领域持续扩大优势
环球市场播报 · 19:45
诺和押注下一发展篇章，礼来在GLP‑1领域持续扩大优势
美股异动 | 医药股上涨，礼来涨近4%
老虎资讯综合 · 09-24 22:23
美股异动 | 医药股上涨，礼来涨近4%
美股医药股逆市走高，礼来涨近4%，辉瑞涨超2%，默沙东、强生涨近2%，诺华制药、诺和诺德涨超1%；AI医疗概念股Temp
智通财经 · 09-24 22:19
美股医药股逆市走高，礼来涨近4%，辉瑞涨超2%，默沙东、强生涨近2%，诺华制药、诺和诺德涨超1%；AI医疗概念股Temp
诺和新战略成败取决于一件它无法生产的东西：投资者信任
环球市场播报 · 09-24 16:47
诺和新战略成败取决于一件它无法生产的东西：投资者信任
异动解读｜诺和诺德盘中下跌3.02%，资本市场日遇冷后抛压延续CEO坦言须重建信心
行情直击 · 09-24 01:27
异动解读｜诺和诺德盘中下跌3.02%，资本市场日遇冷后抛压延续CEO坦言须重建信心
诺和诺德（NVO）瞄准脱发市场 推进后Wegovy多元化增长战略
金吾财讯 · 09-23 21:08
诺和诺德（NVO）瞄准脱发市场 推进后Wegovy多元化增长战略
字节、百度与恒瑞、诺和诺德，抢滩AI制药商业化
蓝鲸财经 · 09-23 20:01
字节、百度与恒瑞、诺和诺德，抢滩AI制药商业化
诺和诺德考虑改变美股上市方式：拟告别ADR、直接登陆纽交所
老虎资讯综合 · 09-23 15:28
诺和诺德考虑改变美股上市方式：拟告别ADR、直接登陆纽交所
诺和诺德资本市场日遇冷：CEO坦言承诺太多、兑现不足，必须重建投资者信心
智通财经 · 09-22
诺和诺德资本市场日遇冷：CEO坦言承诺太多、兑现不足，必须重建投资者信心
诺和诺德（NVO）CagriSema减重效果胜过礼来（LLY）低剂量Zepbound
金吾财讯 · 09-22
诺和诺德（NVO）CagriSema减重效果胜过礼来（LLY）低剂量Zepbound
异动解读｜诺和诺德盘中下跌5.1%，CagriSema数据未消市场疑虑叠加股东施压并购
行情直击 · 09-21
异动解读｜诺和诺德盘中下跌5.1%，CagriSema数据未消市场疑虑叠加股东施压并购
诺和诺德（NVO）跌4.81% 司美格鲁肽被关联罕见致盲眼疾
金吾财讯 · 09-21
诺和诺德（NVO）跌4.81% 司美格鲁肽被关联罕见致盲眼疾
诺和诺德再向礼来“宣战”！CagriSema头对头胜过替尔泊肽，减重12.4%
华尔街见闻 · 09-21
诺和诺德再向礼来“宣战”！CagriSema头对头胜过替尔泊肽，减重12.4%
诺和诺德减重药CagriSema“遇冷”！减重12.4%没能打消市场疑虑
老虎资讯综合 · 09-21
诺和诺德减重药CagriSema“遇冷”！减重12.4%没能打消市场疑虑
异动解读｜诺和诺德盘前下跌3.26%，资本市场日在即股东施压要求推进并购
行情直击 · 09-21
异动解读｜诺和诺德盘前下跌3.26%，资本市场日在即股东施压要求推进并购
诺和诺德股东称公司需通过收购拓展业务
格隆汇 · 09-20
诺和诺德股东称公司需通过收购拓展业务
诺和诺德（NVO）长效生长激素Sogroya®获欧盟CHMP积极意见 拟用于儿科特发性矮小症
金吾财讯 · 09-18
诺和诺德（NVO）长效生长激素Sogroya®获欧盟CHMP积极意见 拟用于儿科特发性矮小症
异动解读｜诺和诺德盘中上涨3.07%，联手Orbis达成14亿美元AI新药合作协议
行情直击 · 09-17
异动解读｜诺和诺德盘中上涨3.07%，联手Orbis达成14亿美元AI新药合作协议
诺和诺德（NVO）联手Orbis加码AI新药研发 部署高达14亿美元合作协议
金吾财讯 · 09-17
诺和诺德（NVO）联手Orbis加码AI新药研发 部署高达14亿美元合作协议
诺和诺德（NVO）与Anthropic达成战略合作 将引入Claude模型赋能新药研发
金吾财讯 · 09-16
诺和诺德（NVO）与Anthropic达成战略合作 将引入Claude模型赋能新药研发
加载更多
公司概况
公司名称：
诺和诺德
所属市场：
NYSE
上市日期：
--
主营业务：
Novo Nordisk A/S成立于1989年，由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球性的医疗保健公司，也是肥胖和糖尿病护理、制造和营销包括GLP-1受体激动剂和现代胰岛素在内的医药产品的世界领先企业。总部位于丹麦，业务遍及约80个国家，产品销往约170个国家。
发行价格：
--
{"stockData":{"symbol":"NVO","market":"US","secType":"STK","nameCN":"诺和诺德","latestPrice":38.6081,"timestamp":1790349916121,"preClose":38.62,"halted":0,"volume":3884790,"delay":0,"changeRate":-0.0003081305023303246,"floatShares":3187922885,"shares":4465000000,"eps":4.003044,"marketStatus":"交易中","change":-0.0119,"latestTime":"09-25 11:25:17 EDT","open":38.81,"high":38.83,"low":38.41,"amount":150011185.27394998,"amplitude":0.010875,"askPrice":38.61,"askSize":1515,"bidPrice":38.6,"bidSize":920,"shortable":3,"etf":0,"ttmEps":4.003044,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1790366400000},"marketStatusCode":2,"adr":1,"adrRate":1,"listingDate":363499200000,"exchange":"NYSE","adjPreClose":38.62,"dividendRate":0.0446,"preHourTrading":{"tag":"盘前","latestPrice":38.83,"preClose":38.62,"latestTime":"09:29 EDT","volume":329474,"amount":12745108.6368,"timestamp":1790342988061,"change":0.21,"changeRate":0.005438,"amplitude":0.009581},"postHourTrading":{"tag":"盘后","latestPrice":38.64,"preClose":38.62,"latestTime":"19:59 EDT","volume":266431,"amount":10284991.6947,"timestamp":1790294372630,"change":0.02,"changeRate":0.000518,"amplitude":0.004358},"volumeRatio":0.532334,"optionData":{"bulkOrders":[{"symbol":"NVO","call":true,"expireDate":1792123200000,"strike":"40.0","timestamp":1790347013870,"price":0.59,"volume":5000,"amount":295000,"type":"-"}]},"impliedVol":0.3452,"impliedVolPercentile":0.0398},"requestUrl":"/m/hq/s/NVO","defaultTab":"news","newsList":[{"id":"2670447830","title":"诺和押注下一发展篇章，礼来在GLP‑1领域持续扩大优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2670447830","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670447830?lang=zh_cn&edition=full","pubTime":"2026-09-25 19:45","pubTimestamp":1790336700,"startTime":"0","endTime":"0","summary":"与此同时，礼来持续蚕食诺和诺德的市场地位，包括快速兴起的口服减肥药赛道。就在诺和诺德努力扭转颓势之际，部分分析师认为，礼来手握多项优势，有望稳固其在肥胖药市场龙头的位置。诺和诺德的口服 Wegovy 片剂抢先上市，比礼来竞品 Foundayo 早数月，公司希望借此守住口服减重赛道的先发优势。礼来 8 月披露，其二季度在美国 GLP1 市场份额约61%，诺和诺德约39%。里辛格称，礼来拥有下一代肥胖药管线，有望在 Zepbound 和 Foundayo 之外继续扩大领先优势。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-25/doc-iniszvzv7702421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1232071149.USD","LU2237443622.USD","LU2023251221.USD","LU2461242641.AUD","MHIP","SGXZ31699556.SGD","LU0320765992.SGD","IE00B1BXHZ80.USD","NVOH","AGNG","LU2023250330.USD","IE00BK4W5M84.HKD","LU2023250504.SGD","LU2361044865.SGD","LU2089984988.USD","LU0256863811.USD","LU0820562030.AUD","SG9999001176.USD","LU0256863902.USD","LU0354030511.USD","LU2360106947.USD","LU0079474960.USD","LU1868837300.USD","IE00BFTCPJ56.SGD","LU1629891620.HKD","LU1093756325.SGD","FTXH","BK4534","THNR","LU0158827781.USD","IE0005OL40V9.USD","LU2271345857.HKD","BK4007","LU0823434583.USD","LU1548497426.USD","LU1868836914.USD","IE00BWXC8680.SGD","LU1988902786.USD","LU1974910355.USD","LU2168564065.EUR","LU1868836591.USD","LU2462157665.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU0158827948.USD","SG9999014898.SGD","LU0640476718.USD","LU0109391861.USD","LU1551013425.SGD","IE00BK4W5L77.USD","LU2063271972.USD","LU1267930730.SGD","LU2471134796.USD","LU2471134952.CNY","LU0823434740.USD","LU2111349929.HKD","SGXZ51526630.SGD","LU2462591350.SGD","IE0001KFT4U8.USD","LU0471298777.SGD","LU0708995401.HKD","SG9999014914.USD","MEDI","SG9999014880.SGD","LU0820561909.HKD","LU1064131342.USD","CANC","LU1291159041.SGD","LU2746668461.USD","LU1989771016.USD","HRTS","BK4533","MEDX","SGXZ81514606.USD","LU2357305700.SGD","TMED","LU0320765059.SGD","IE00BKVL7J92.USD","LU2089283258.USD","LU0198837287.USD","LU0203201768.USD","LU2491050154.USD","SG9999014906.USD","LU1983299246.USD","SG9999018865.SGD","LU2491050071.SGD","LU2089284900.SGD","IE00B4JS1V06.HKD","LU2361045086.USD","LU1691799644.USD","LU2028103732.USD","LU0109394709.USD","LU0943347566.SGD","LU2211815571.USD","LU2264538146.SGD","LU0122379950.USD","LU0353189680.USD","LLII","LU0882574139.USD","LU0106261372.USD","LU0174119429.USD","GDOC","LLYZ","IE0004445239.USD","LU0316494557.USD","LU1868836757.USD","SG9999015952.SGD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU1035775433.USD","ELIL","IE00BN29S564.USD","IE0009355771.USD","LU1720051108.HKD","LU0471298694.HKD","LU0097036916.USD","LU0114720955.EUR","LU0820561818.USD","LU0964807845.USD","LU2106854487.HKD","NVO","FHLC","IE0002141913.USD","LU1093756168.USD","LU2324357040.USD","LU2896262040.SGD","LU1280957306.USD","LU0432979614.USD","LU2108987350.USD","BK4588","BK4581","LU2168564222.USD","LU2552382058.USD","LU2750360997.AUD","IE00BJT1NW94.SGD","LU1917777945.USD","LU0006306889.USD","LU1323610961.USD","LU2491049909.HKD","ELIS","LU1868837136.USD","LU2265009873.SGD","IE00BJLML261.HKD","LU2471134879.HKD","IE00BZ1G4Q59.USD","LU2552382132.HKD","BK4516","LU1979441026.SGD","OZEM","XLV","LU0225283273.USD","LU1804176565.USD","PJP","SG9999015945.SGD","LU0323591593.USD","LU2168564495.EUR","LU2237443978.SGD","LU1145028129.USD","LU2237443465.HKD","LU0133085943.USD","LU2750360641.GBP","LU0672654240.SGD","CURE","LU1069344957.HKD","LU1720051017.SGD","LU1061106388.HKD","LU2471134523.USD","SG9999017495.SGD","SG9999001176.SGD","NVOX","SG9999013999.USD","LU2112291526.USD","LU0889565916.HKD","TRUH","IE0004445015.USD","ILDR","WDNA","LU0234572021.USD","LU2746668974.SGD","GB00BDT5M118.USD","LU2602419157.SGD","LU1127390331.HKD","LU0345770308.USD","LU0238689110.USD","IE00BJJMRX11.SGD","SG9999015978.USD","LU1623119135.USD","PPH","LU2237443549.SGD","VHT","LU1551013342.USD","LU2417539215.USD","LU0154236417.USD","LLYX","LU1366192091.USD","IE00B7KXQ091.USD","LU2756315664.SGD","IE00B4R5TH58.HKD","LU0786609619.USD","IE00BJJMRY28.SGD","LU0266013472.USD","LU0061475181.USD","LU0385154629.USD","BK4532","LU0354030438.USD","LU0689472784.USD","LU0882574055.USD","IE00BFSS7M15.SGD","LU0466842654.USD","LU2213496289.HKD","LU0203202063.USD","LU0683600562.USD","BK4599","LU2236285917.USD","SG9999015986.USD","SGXZ57979304.SGD","LU0417517546.SGD","LU1712237335.SGD","LU2237443895.HKD","LU0823416689.USD","LU0787776722.HKD","IE00BKDWB100.SGD","LU1057294990.SGD","IE00B1XK9C88.USD","LU0210536198.USD","LU2756315318.SGD","LU0353189763.USD","LU2468319806.SGD","NVOC","JDOC","LU0345770993.USD","LU2168563687.JPY","IE00B775H168.HKD","BK4585","LU2361044949.HKD","LU0058720904.USD","LU0094547139.USD","RXL","LU0456855351.SGD","LU0096364046.USD","LU2456880835.USD","SG9999018857.SGD","IYH","LU1814569148.SGD","LU2087625088.SGD","LU2168564149.EUR","IE00BFSS8Q28.SGD","LU2552382215.SGD","IXJ","IE00BKPKM429.USD","SGXZ99366536.SGD","LU2237438978.USD","LU2237443382.USD","LLY","IHE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159199811","title":"美股异动 | 医药股上涨，礼来涨近4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159199811","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159199811?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:23","pubTimestamp":1790259829,"startTime":"0","endTime":"0","summary":"9月24日，美股医药股上涨，礼来涨近4%，辉瑞涨超2%，默沙东、强生涨近2%，诺华、诺和诺德涨超1%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","LU2491050154.USD","LU0097036916.USD","IE0002270589.USD","LU1712237335.SGD","IE00BVYPNW00.USD","LU2237443465.HKD","LU0417517546.SGD","IE00BWXC8680.SGD","LABD","LU0786609619.USD","LU1934455863.HKD","LU2468319806.SGD","LU2471134952.CNY","BK4550","LU2505996509.AUD","LU2111349929.HKD","LU0345769631.USD","IE00BGHQF631.EUR","LU0114720955.EUR","LU0994945656.USD","GDOC","LU0320765489.SGD","LU0683600562.USD","LU1221951046.USD","LU2361044949.HKD","IE00BBT3K403.USD","SG9999001176.USD","THNR","SG9999002232.USD","SG9999015986.USD","LU0320765059.SGD","SG9999002224.SGD","LU2357627491.SGD","LU0792757196.USD","SG9999018865.SGD","LU0965509010.AUD","LU2491050071.SGD","LU1093756325.SGD","IE00BJLML261.HKD","LU0265550359.USD","IE0001KFT4U8.USD","LU2089984988.USD","LU0234572021.USD","SGXZ31699556.SGD","LU2023250504.SGD","LU0648001328.SGD","LU1551013425.SGD","LU1267930813.SGD","LU1244550577.SGD","LU0859254822.USD","LU0823434583.USD","MEDX","WDNA","LU0225771236.USD","LU2756315664.SGD","LU1983299246.USD","IE0004445239.USD","BK4516","LU1979441026.SGD","LU2168564222.USD","PFE","LU1323610961.USD","LU1023059063.AUD","BK4504","LU0861579265.USD","LU0965509283.SGD","LU0949170772.SGD","LU0256863902.USD","LU1066051498.USD","IE00BJJMRY28.SGD","LU1778281490.HKD","LU2361044865.SGD","XLV","BK4585","LU1035773651.USD","IE00BFSS8Q28.SGD","LU0385154629.USD","LU2487616109.SGD","LLY","LU2089283258.USD","SG9999001440.SGD","NVOH","LU0426417589.USD","LU0354030438.USD","LU1551013342.USD","LU2750360997.AUD","BK4599","SG9999017495.SGD","LU0787776722.HKD","LU0069063385.USD","LU2552382132.HKD","HRTS","BMED","LU0353189763.USD","SGXZ57979304.SGD","LU0053666078.USD","IE00B19Z3B42.SGD","PAWZ","AGNG","LU1035775433.USD","LU0256863811.USD","LU2237443895.HKD","LU1228905540.USD","LU2168564149.EUR","LU0057025933.USD","LU1093756168.USD","LU1043141123.HKD","LU0354030511.USD","LU2456880835.USD","LU1914381329.SGD","IE00BJJMRX11.SGD","LU1244550221.USD","LU0234570918.USD","LU0306807586.USD","LU0098860793.USD","SG9999011175.SGD","OZEM","LU0472753341.HKD","NVOC","LU0109394709.USD","LU0289739699.SGD","IYH","SG9999014898.SGD","SG9999014880.SGD","LU2471134523.USD","FHLC","LU2746668974.SGD","BK4532","BK4592","LU0471298777.SGD","LU1043141396.HKD","SG9999015952.SGD","SGXZ51526630.SGD","IE00BKDWB100.SGD","LU0198837287.USD","LU0094547139.USD","JNJ","LU2028103732.USD","LU0109391861.USD","IE0034235303.USD","LU0795875169.SGD","LU0912757837.SGD","LU0889565916.HKD","LU1366192091.USD","ELIL","LU2237438978.USD","NVS","LU1585245621.USD","IE00B7KXQ091.USD","LU0738911758.USD","LU1069347547.HKD","LU2168564495.EUR","LU0130517989.USD","LU2023250330.USD","LU0321505439.SGD","LU2106854487.HKD","LU2552382215.SGD","LU2417539215.USD","IE00BSNM7G36.USD","LLYZ","IE00BK4W5M84.HKD","LU0203201768.USD","IE000M9KFDE8.USD","LU0456855351.SGD","LU0661504455.SGD","LU0965509101.SGD","LLII","LU0238689110.USD","LU1506573853.SGD","LU1037948541.HKD","IE00B1XK9C88.USD","LU0203202063.USD","LU1868837136.USD","IE00B42XCP33.USD","IXJ","LU0511384066.AUD","LU0158827781.USD","RXL","BK4581","LU1228905037.USD","BK1574","LU1868837300.USD","LU2596442595.SGD","IE00BN8TJ469.HKD","LU1037948897.HKD","LU0868494617.USD","LU2271345857.HKD","LU1814569148.SGD","LU0070302665.USD","LU1868836591.USD","LU0466842654.USD","LU0426412945.USD","NVO","IE00B4JS1V06.HKD","LU0096364046.USD","SG9999015358.SGD","LU2211815571.USD","SG9999015341.SGD","LU2324357040.USD","IE00BKVL7J92.USD","LU0943347566.SGD","IE00BLSP4239.USD","LU1196500208.SGD","IE00BDGV0183.EUR","BK1161","LU0265550946.USD","LU2403377893.USD","LU2360032135.SGD","IE00B775H168.HKD","IE00BN29S564.USD","LU2361045086.USD","LU0130102774.USD","LU1623119135.USD","LU0122379950.USD","LU0820561909.HKD","LU2433249047.HKD","LU0868494708.USD","IHE","LU2087625088.SGD","LU2129689431.USD","IE00B7SZLL34.SGD","LU1929549753.HKD","BK4578","LU1032466523.USD","LU1059921491.USD","LU2471134879.HKD","LU0985320562.USD","LU1201861249.SGD","LU1244550494.USD","LU1571399168.USD","LU1883839398.USD","SG9999014567.USD","LU0162691827.USD","LU1868836914.USD","IE00B2B36J28.USD","LU1629891620.HKD","LU1941712264.USD","LU1232071149.USD","LU0061475181.USD","IE00BJT1NW94.SGD","SGXZ99366536.SGD","BK7104","IE000SO60NU8.SGD","LU0689472784.USD","LU0795875086.SGD","PPH","TRUH","LU0210528500.USD","IE0005OL40V9.USD","LU1069344957.HKD","LU1941712348.USD","LU0553294199.USD","MHIP","LU0672654240.SGD","LU1691799644.USD","LU0545562505.USD","LU1496350502.SGD","PJP","FTXH","LU0640476718.USD","LU1989772840.SGD","LU2112291526.USD","LU2023250843.SGD","LU0072461881.USD","LU1116320737.USD","LU0210536198.USD","LU1127390331.HKD","BK4534","LU0208291251.USD","LU1868836757.USD","GB00BDT5M118.USD","LU0345770308.USD","LU0820561818.USD","CANC","SG9999001176.SGD","LU2750360641.GBP","LU0133085943.USD","IE00B3T34201.USD","LU1732799900.SGD","LU2505996681.GBP","LU0345770993.USD","LU1145028129.USD","MEDI","LU2129689605.HKD","LU1974910355.USD","LU1674673691.USD","LU0203345920.USD","LU0170899867.USD","LU2430703095.HKD","159938","IE0002141913.USD","LU1917777945.USD","LU1548497426.USD","SG9999013999.USD","LU2430703251.USD","LU0323591593.USD","LU2125909247.SGD","LU1003077747.HKD","SG9999003800.SGD","LU1291159041.SGD","LU0820562030.AUD","LU0980610538.SGD","LU2168563687.JPY","LU2125154935.USD","LU0882574055.USD","LU0203347892.USD","IE00BZ1G4Q59.USD","SG9999018857.SGD","LU0289739343.SGD","LU0321505868.SGD","SG9999014559.SGD","IE00BLSP4452.SGD","LU2756315318.SGD","LU0154236417.USD","LU0124676726.USD","SGXZ80539844.SGD","LU2602419157.SGD","LU0320765646.SGD","LU1720051108.HKD","SG9999014575.USD","LU1720051017.SGD","LU0070217475.USD","LU2357305700.SGD","LU2237443549.SGD","LU1894683348.USD","LU0316494557.USD","LU0432979614.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4533","LU0225284248.USD","CURE","BK4559","LU0058720904.USD","LU2471134796.USD","LU0823434740.USD","LU2129689514.USD","LU2462591350.SGD","LU2063271972.USD","IE000BZT7R73.USD","IE0009355771.USD","LU0289961442.SGD","LU1162221912.USD","BGIA","LU1989771016.USD","IE00BFSS7M15.SGD","SG9999015945.SGD","LU1989772923.USD","LU2125909593.SGD","LU0158827948.USD","SGXZ81514606.USD","LU0823416689.USD","LU2023251221.USD","LU2746668461.USD","LU0174119429.USD","LU1923622614.USD","LU1116320901.HKD","JDOC","LU1066051811.HKD","LU1074936037.SGD","LU0306806265.USD","LU0477156953.USD","LU1057294990.SGD","BK1515","LU0266013472.USD","LU0225283273.USD","IE00BFTCPJ56.SGD","LU1894683264.USD","BK4007","LU0882574139.USD","ILDR","LU2168564065.EUR","LU0211331839.USD","LU1267930730.SGD","LU1934455277.USD","IE000MB6IJN5.SGD","IE00BK4W5L77.USD","LU2265009873.SGD","BK4588","LU1699723380.USD","SG9999015978.USD","LU1430594728.SGD","LU2133065610.SGD","LU1988902786.USD","LU2592432038.USD","LU2461242641.AUD","LU0708995401.HKD","LU0689626769.HKD","LU2430703178.SGD","LU2213496289.HKD","LU2236285917.USD","BK7095","LU0079474960.USD","LU2237443978.SGD","IE0000B7K699.USD","LU1061106388.HKD","LU1934455194.USD","LU0965508806.USD","LU0006306889.USD","LU2264538146.SGD","LU2347655156.SGD","IE000F7OJYX1.SGD","LU2491049909.HKD","IE00BVYPNV92.GBP","IE00B1BXHZ80.USD","LU0106261372.USD","LU1121112475.USD","LU2125154778.USD","LU1032955483.USD","LU2237443622.USD","LU1066053197.SGD","LU0985481810.HKD","LU1261432733.SGD","IE00B3PB1722.GBP","LU1221951129.SGD","SG9999014914.USD","TMED","LU2108987350.USD","IE00BFXG1179.USD","LU1718418525.SGD","IE00BKPKM429.USD","LU0353189680.USD","LLYX","ELIS","LU0942090050.USD","LU1732800096.USD","LU2462157665.USD","LU2360106947.USD","LU0889566641.SGD","LU0964807845.USD","NVOX","LU1804176565.USD","SG9999014542.SGD","VHT","LU2896262040.SGD","LU1064131342.USD","IE000WAW04H5.SGD","LU2237443382.USD","LU0345769128.USD","LU0471298694.HKD","LU0320765992.SGD","MRK","LU1066051225.USD","LU1674673428.USD","LU0545039389.USD","IE00B19Z3581.USD","IE0004445015.USD","LU1280957306.USD","LU2089284900.SGD","SG9999014906.USD","LU1935042991.SGD","LU2552382058.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669496056","title":"美股医药股逆市走高，礼来涨近4%，辉瑞涨超2%，默沙东、强生涨近2%，诺华制药、诺和诺德涨超1%；AI医疗概念股Temp","url":"https://stock-news.laohu8.com/highlight/detail?id=2669496056","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669496056?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:19","pubTimestamp":1790259582,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0787776722.HKD","BK4516","LU2237443622.USD","LU0912757837.SGD","LU1585245621.USD","LU0320765489.SGD","LU0203345920.USD","LU1228905037.USD","SG9999011175.SGD","LU2168564065.EUR","LU0426412945.USD","LU1623119135.USD","LU0265550359.USD","LU1221951046.USD","LU0256863902.USD","MEDX","LU0823416689.USD","LU0345769128.USD","LU1934455194.USD","LU1894683348.USD","LU0130517989.USD","LU2471134879.HKD","IE000MB6IJN5.SGD","BK4532","LU2430703095.HKD","SG9999014906.USD","LU2433249047.HKD","AGNG","LU2063271972.USD","LU0868494617.USD","LU1043141396.HKD","LU1551013425.SGD","IE00BK4W5M84.HKD","SG9999015978.USD","LU2089283258.USD","LU1093756325.SGD","HRTS","PAWZ","LU0385154629.USD","LU2347655156.SGD","LU0738911758.USD","CANC","LU0417517546.SGD","LU1059921491.USD","LU0234572021.USD","LU1196500208.SGD","LU1003077747.HKD","LU0980610538.SGD","SG9999001440.SGD","BK4504","IE0001KFT4U8.USD","LU0225284248.USD","LU1145028129.USD","LU1023059063.AUD","LU1868836757.USD","LU0070217475.USD","LU0820561818.USD","LU1720051108.HKD","LU0795875169.SGD","LU0477156953.USD","LU2129689605.HKD","LU1035773651.USD","SG9999015945.SGD","BK4588","LU2756315664.SGD","LU1674673428.USD","LU1868836591.USD","LU2236285917.USD","VHT","LU0306807586.USD","LU0238689110.USD","LU1917777945.USD","MHIP","LU2596442595.SGD","LU2361044949.HKD","IE00B7KXQ091.USD","LU0545562505.USD","LU2264538146.SGD","LU1069344957.HKD","LU2108987350.USD","BK4578","LU2112291526.USD","BK4007","LU2271345857.HKD","LU1244550494.USD","LU2237443895.HKD","WDNA","IE00BN8TJ469.HKD","FHLC","IE00B42XCP33.USD","SG9999018857.SGD","SG9999014914.USD","LU0823434740.USD","IE00BWXC8680.SGD","LU1066051498.USD","PPH","IE00B19Z3B42.SGD","TRUH","LU0133085943.USD","LU2125909593.SGD","LU0985481810.HKD","LU0321505439.SGD","GDOC","LU0353189680.USD","IE000SO60NU8.SGD","LU1267930813.SGD","LU0320765992.SGD","LU1221951129.SGD","BK4581","IE0009355771.USD","IE000BZT7R73.USD","SGXZ81514606.USD","ILDR","ELIS","LU1043141123.HKD","LU1162221912.USD","SGXZ31699556.SGD","LU2430703251.USD","IE00B19Z3581.USD","LU0109391861.USD","LU1712237335.SGD","GB00BDT5M118.USD","LU0786609619.USD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","THNR","LU0154236417.USD","LU0868494708.USD","IE00B775H168.HKD","IE00BFSS8Q28.SGD","LU2491049909.HKD","LU2487616109.SGD","LU0061475181.USD","LU1116320737.USD","NVOH","IE00BVYPNV92.GBP","LU0432979614.USD","LU0097036916.USD","IE00BVYPNW00.USD","LU2111349929.HKD","LU0203202063.USD","LU0820561909.HKD","LU0320765059.SGD","LU1989772840.SGD","OZEM","LU1548497426.USD","IE0002270589.USD","LU0158827781.USD","LU0210536198.USD","LU2360032135.SGD","LU2125154778.USD","LU0466842654.USD","LU1061106388.HKD","SG9999014898.SGD","LU1280957306.USD","LU0069063385.USD","SG9999014575.USD","LU0823434583.USD","LU0289739699.SGD","LU2592432038.USD","LU1127390331.HKD","LU2417539215.USD","LU2552382132.HKD","SG9999014567.USD","LU2087625088.SGD","LU0114720955.EUR","LU0130102774.USD","LU0861579265.USD","LU1814569148.SGD","IE00BJJMRX11.SGD","LU1883839398.USD","LU0203201768.USD","LU1066051811.HKD","LU2237438978.USD","SGXZ99366536.SGD","LU0053666078.USD","PFE","SG9999015358.SGD","LU0994945656.USD","SG9999015986.USD","LU0208291251.USD","FTXH","LU0965509283.SGD","LU2028103732.USD","LU2129689431.USD","LU0070302665.USD","LU2168564222.USD","LU1929549753.HKD","LU0472753341.HKD","LU1934455863.HKD","LU0882574139.USD","IE00B2B36J28.USD","LU0354030438.USD","LU0672654240.SGD","LU0210528500.USD","LU2403377893.USD","LU0106261372.USD","IE0004445239.USD","LU0964807845.USD","LU2896262040.SGD","LU2491050071.SGD","NVO","LU2456880835.USD","LU2237443549.SGD","LU0942090050.USD","LU2168563687.JPY","IE0005OL40V9.USD","IE00BJT1NW94.SGD","LU0122379950.USD","BK4550","LU0266013472.USD","LU2357627491.SGD","LU0648001328.SGD","LU1979441026.SGD","LU0345770993.USD","IE00BLSP4452.SGD","LU2361044865.SGD","LU0316494557.USD","LU0471298694.HKD","LU1732800096.USD","SG9999018865.SGD","LU1983299246.USD","BK4599","LU0426417589.USD","LU2125154935.USD","LU2168564149.EUR","LU0985320562.USD","LU2089284900.SGD","LU2023250330.USD","LU1121112475.USD","LU1720051017.SGD","LU0170899867.USD","LU2750360641.GBP","IE00BBT3K403.USD","LU0306806265.USD","PJP","SG9999013999.USD","IE000F7OJYX1.SGD","LU1261432733.SGD","LU1074936037.SGD","LU0949170772.SGD","LU2430703178.SGD","LU1868837300.USD","BK4568","LU2133065610.SGD","SG9999003800.SGD","LU0354030511.USD","LU1571399168.USD","SGXZ80539844.SGD","LU0965508806.USD","SG9999014880.SGD","IE000WAW04H5.SGD","LU2324357040.USD","LU2746668461.USD","LU0198837287.USD","LU1366192091.USD","IE00B4JS1V06.HKD","IE000M9KFDE8.USD","LU1974910355.USD","IE0004445015.USD","IE00BKDWB100.SGD","LU2361045086.USD","IE00BFSS7M15.SGD","LU0683600562.USD","LU0072461881.USD","LU1923622614.USD","LU0820562030.AUD","LU0265550946.USD","LLYX","LU0079474960.USD","IE00BJJMRY28.SGD","LU2360106947.USD","LU1032955483.USD","IE00BJJMRZ35.SGD","LU0203347892.USD","BK4534","LU1935042991.SGD","LU2023250843.SGD","IE00BFXG1179.USD","LU2750360997.AUD","LU0792757196.USD","LU0225283273.USD","TMED","LU0943347566.SGD","IE00BK4W5L77.USD","LU2023250504.SGD","IE00BZ1G4Q59.USD","LU2471134952.CNY","LU0471298777.SGD","LU0094547139.USD","LU1691799644.USD","BK4559","IE00B4R5TH58.HKD","LU0256863811.USD","SG9999002224.SGD","LU2462591350.SGD","LU2089984988.USD","LU0889566641.SGD","SG9999001176.USD","LU1988902786.USD","BK4592","LU0965509010.AUD","LU1066053197.SGD","LU0162691827.USD","LU1066051225.USD","LU1934455277.USD","IE00BGHQF631.EUR","LU0058720904.USD","LU1032466523.USD","LU1989772923.USD","LU2213496289.HKD","LU0640476718.USD","LU2756315318.SGD","LU0321505868.SGD","LU2237443465.HKD","LU0124676726.USD","SG9999002232.USD","SGXZ51526630.SGD","LU1116320901.HKD","LU0545039389.USD","LU1674673691.USD","BK4585","LU0511384066.AUD","IE00B1BXHZ80.USD","LU1201861249.SGD","LU1057294990.SGD","LU0098860793.USD","RXL","LU0096364046.USD","SG9999001176.SGD","LU1496350502.SGD","LU2462157665.USD","IE00B3T34201.USD","SG9999014559.SGD","LU0289961442.SGD","LU1506573853.SGD","SG9999015952.SGD","IE00B1XK9C88.USD","LU1778281490.HKD","JNJ","IE00B3PB1722.GBP","IE00BKVL7J92.USD","SG9999017495.SGD","LU0006306889.USD","LU0174119429.USD","LU1291159041.SGD","LU0289739343.SGD","LU1232071149.USD","NVOX","LU1718418525.SGD","LU2471134523.USD","LU2471134796.USD","MRK","LU0708995401.HKD","LU2106854487.HKD","LU0661504455.SGD","LU1069347547.HKD","LU2125909247.SGD","LU0057025933.USD","LU0689626769.HKD","LU2211815571.USD","LU1323610961.USD","SGXZ57979304.SGD","LU0211331839.USD","LU2552382215.SGD","LU0965509101.SGD","LU1228905540.USD","LU0320765646.SGD","LLII","CURE","LU1551013342.USD","LU2746668974.SGD","LU2357305700.SGD","LU2129689514.USD","IHE","LU0456855351.SGD","LU0889565916.HKD","LLY","LU1804176565.USD","LU0345770308.USD","LU0553294199.USD","LU1037948897.HKD","LU1037948541.HKD","XLV","LU1699723380.USD","SG9999014542.SGD","MEDI","IE00BFTCPJ56.SGD","LU1035775433.USD","LU1244550221.USD","LU1267930730.SGD","LU2552382058.USD","LU2505996681.GBP","SG9999015341.SGD","LU0345769631.USD","BK4533","LU2505996509.AUD","LU2491050154.USD","IE0000B7K699.USD","JDOC","LU2602419157.SGD","LU2237443382.USD","LU0225771236.USD","NVS","IE00BKPKM429.USD","IYH","LU1629891620.HKD","IE00BLSP4239.USD","IE00BDGV0183.EUR","LU0158827948.USD","LU1868836914.USD","LU2265009873.SGD","LU1093756168.USD","LU0323591593.USD","IE00BN29S564.USD","IE0002141913.USD","LU1894683264.USD","LU2168564495.EUR","LLYZ","LU1989771016.USD","IXJ","LU0689472784.USD","IE0034235303.USD","LU2468319806.SGD","LU0795875086.SGD","LU0109394709.USD","LU0859254822.USD","LU0882574055.USD","LU1430594728.SGD","LU1914381329.SGD","NVOC","IE00BJLML261.HKD","LU2237443978.SGD","LU2023251221.USD","LU1941712264.USD","LU0234570918.USD","LU2461242641.AUD","LU1064131342.USD","LU1868837136.USD","LU1244550577.SGD","LU0353189763.USD","LU1941712348.USD","BMED","LU1732799900.SGD","ELIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669246372","title":"诺和新战略成败取决于一件它无法生产的东西：投资者信任","url":"https://stock-news.laohu8.com/highlight/detail?id=2669246372","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669246372?lang=zh_cn&edition=full","pubTime":"2026-09-24 16:47","pubTimestamp":1790239620,"startTime":"0","endTime":"0","summary":"诺和诺德股价已经明显落后头号对手礼来。诺和诺德计划扩大产能，到 2030 年，口服减重药可服务的肥胖患者规模提升至当前十倍，同期还要推动另外四款口服肥胖新药推向市场。维格威司美格鲁肽口服片剂诺和诺德向投资者表示，多重肥胖治疗药物、强大的口服产品矩阵，叠加糖尿病肥胖以外的新业务板块，将构筑自身竞争优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-24/doc-inisxnvc0348361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","NVO","LU1093756168.USD","LU0154236417.USD","PPH","BK4007","NVOC","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4532","OZEM","LU1093756325.SGD","NVOH","BK4599","BK4585","NVOX","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106076955","title":"异动解读｜诺和诺德盘中下跌3.02%，资本市场日遇冷后抛压延续CEO坦言须重建信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1106076955","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106076955?lang=zh_cn&edition=full","pubTime":"2026-09-24 01:27","pubTimestamp":1790184432,"startTime":"0","endTime":"0","summary":"9月24日，诺和诺德盘中下跌3.02%，报38.215美元/股，成交额4.59亿美元，股价创近期新低。消息面上，公司近日举办的资本市场日引发持续抛压。新任CEO杜斯塔尔公开坦言\"承诺过多、兑现不足\"，须重建投资者信心。公司承诺2030年推出五款以上重磅新药、2035年管线新增销售额超230亿美元，但市场认为该指引被重申而非上调，缺乏增长细节。此外，摩根士丹利此前已将公司评级下调至减持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德股价下跌，投资者信心承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669748604","title":"诺和诺德（NVO）瞄准脱发市场 推进后Wegovy多元化增长战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2669748604","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669748604?lang=zh_cn&edition=full","pubTime":"2026-09-23 21:08","pubTimestamp":1790168913,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德（NVO）正考虑布局脱发治疗赛道。作为Ozempic、Wegovy的研发药企，公司将探索脱发领域作为“后Wegovy”增长战略的一部分，谋求业务多元化。诺和诺德首席科学官Martin Lange表示，公司可依托自身科研能力切入脱发领域。他同时称，脱发项目不一定是优先推进的方向，但属于明确的潜在机会。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/NzFhNTI4MGUwYzI0YmU3ZWQ0MDcxNDc2MTkyOTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NzFhNTI4MGUwYzI0YmU3ZWQ0MDcxNDc2MTkyOTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306397","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","NVOH","IE00BZ1G4Q59.USD","LU0154236417.USD","NVO","THNR","LU1093756325.SGD","BK4007","BK4532","LU1093756168.USD","OZEM","BK4585","PPH","NVOC","BK4599","NVOX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669762483","title":"字节、百度与恒瑞、诺和诺德，抢滩AI制药商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2669762483","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669762483?lang=zh_cn&edition=full","pubTime":"2026-09-23 20:01","pubTimestamp":1790164907,"startTime":"0","endTime":"0","summary":"截图来源于港股公告叠加字节跳动将AI制药业务独立拆分设立Anew Labs这一动作，入局AI制药的大厂阵营还在持续扩容。目前，行业已有落地成果佐证AI的前端价值。港股龙头英硅智能的发展路径，展现了当前AI药企的部分商业化现状。截图来源于港股公告这份增速亮眼的财报，证明AI技术具备即时商业变现能力。AI技术模型可以加快新药研发的起点，但从这条赛道跑出来的玩家，大概率是率先实现临床转化与商业化落地的那个。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789979347715387090","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU2097828714.EUR","BK4574","BK4588","LU1064131003.USD","BIDU","LU2289578879.USD","BK4602","01276","LU1328615791.USD","LU0154236417.USD","LU0405327148.USD","LU1781817850.SGD","BK4514","LU0287142896.SGD","LU2097828557.USD","LU2580892862.HKD","LU1093756168.USD","BK0183","BK4532","IE00BKVL7J92.USD","LU0359202008.SGD","LU0173614495.USD","NVOH","LU0640798160.USD","BK4504","LU2495084118.USD","NVOC","LU2328871848.SGD","LU1997245177.USD","BK4535","02257","IE00BZ1G4Q59.USD","BK4526","09888","LU1655091616.SGD","LU1997245094.SGD","LU1580142542.USD","LU2148510915.USD","PPH","600276","LU2097828805.USD","BK4585","BK4612","LU1146622755.USD","LU2488822045.USD","BK0060","DRGN","LU1023057109.AUD","LU1969619763.USD","LU2097828631.EUR","BK4531","LU2097828474.EUR","LU0405327494.USD","LU1820825898.SGD","NVO","BK4007","LU1064130708.USD","LU1093756325.SGD","LU0359201612.USD","BK0012","BK4543","BIDG","BK4599","BK4587","BK4552","KBDU","BK1161","BK0196","NVOX","BK4077","BK4579","LU1255011170.USD","BK4614","BK0188","IE00B0JY6N72.USD","LU1997244956.HKD","BK0028","LU2580892789.USD","OZEM","BK4548","BK0239","THNR","LU1115378108.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106047860","title":"诺和诺德考虑改变美股上市方式：拟告别ADR、直接登陆纽交所","url":"https://stock-news.laohu8.com/highlight/detail?id=1106047860","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106047860?lang=zh_cn&edition=full","pubTime":"2026-09-23 15:28","pubTimestamp":1790148494,"startTime":"0","endTime":"0","summary":"诺和诺德正考虑改变美国投资者持有公司股票的方式，以进一步提升其在华尔街的影响力。","market":"us","thumbnail":"https://community-static.tradeup.com/news/7b57cba2d68c92ee95b1cc87b70c41f0","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7b57cba2d68c92ee95b1cc87b70c41f0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德考虑改变美股上市方式：拟告别ADR、直接登陆纽交所","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOC","NVO","NVOH","NVOX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2669987110","title":"诺和诺德资本市场日遇冷：CEO坦言承诺太多、兑现不足，必须重建投资者信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2669987110","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669987110?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:13","pubTimestamp":1790082780,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺和诺德首席执行官迈克·杜斯塔尔周二在一次采访中表示，公司必须付出更多努力来重建投资者信心，因为这家Ozempic制造商旗下最大药物将在下一个十年初面临专利悬崖。诺和诺德股价周一出现下挫，因为这家丹麦制药公司的资本市场日让投资者对其转型计划的细节缺失感到失望。诺和诺德承诺到2030年推出五款以上重磅新药，到2035年新增销售额超过230亿美元。","market":"fut","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499312.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NVOH","NVO","NVOC","BGIA","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669110867","title":"诺和诺德（NVO）CagriSema减重效果胜过礼来（LLY）低剂量Zepbound","url":"https://stock-news.laohu8.com/highlight/detail?id=2669110867","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669110867?lang=zh_cn&edition=full","pubTime":"2026-09-22 16:58","pubTimestamp":1790067492,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德 公布Ⅲ期临床试验结果，其在研每周一次肥胖症疗法CagriSema，对比竞争对手礼来每周注射剂Zepbound5mg剂量，取得更佳减重效果。REIMAGINE 5试验入组2型糖尿病成人患者，第60周数据显示，CagriSema 1mg/1mg预估平均减重12.4%，Zepbound组减重9.1%；CagriSema降低HbA1c的效果同样达到对Zepbound的非劣效标准。在针对超重、肥胖患者的REDEFINE 9试验中，CagriSema组减重21%，安慰剂组减重2%，该项研究未设置Zepbound对照。tirzepatide还由礼来以Mounjaro商品名用于2型糖尿病治疗，剂量范围相同。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/OTc4NDY1YzgwYTY5ZDI5OGQwMTAxMzU2NDM1Mjg5Ng==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/OTc4NDY1YzgwYTY5ZDI5OGQwMTAxMzU2NDM1Mjg5Ng==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306310","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","LU2491049909.HKD","LU2028103732.USD","LU0096364046.USD","LU0256863902.USD","LLY","SG9999018857.SGD","SGXZ51526630.SGD","GDOC","SG9999017495.SGD","BK4516","IYH","SGXZ81514606.USD","ELIS","LU1291159041.SGD","WDNA","LU0109394709.USD","LU0154236417.USD","LU2746668461.USD","IHE","LU1064131342.USD","LU0158827781.USD","LU0823434583.USD","MEDI","LU2471134879.HKD","LU0353189680.USD","IE0004445239.USD","LU2360106947.USD","LU2265009873.SGD","LU2471134523.USD","LU2552382132.HKD","LU2112291526.USD","LU2211815571.USD","IE00BFSS8Q28.SGD","LU0203201768.USD","SG9999013999.USD","LU0943347566.SGD","BK4599","LU1267930730.SGD","IE00B1BXHZ80.USD","FHLC","LU0097036916.USD","LU1093756168.USD","LU1868837300.USD","LU0316494557.USD","LU2361044949.HKD","LU2237443382.USD","LU1720051017.SGD","LU0210536198.USD","SG9999001176.SGD","LU2896262040.SGD","SG9999015945.SGD","LLYX","LU1061106388.HKD","LU0106261372.USD","LU0234572021.USD","LU2361045086.USD","IE00B775H168.HKD","LLII","LU1551013425.SGD","LU2106854487.HKD","LU2237443895.HKD","LU2023250504.SGD","LU1232071149.USD","CANC","IE0009355771.USD","LU1629891620.HKD","LU1868836757.USD","LU1917777945.USD","LU2237443465.HKD","SG9999001176.USD","OZEM","SG9999014914.USD","LU0683600562.USD","LU0345770308.USD","LU2471134796.USD","LU0094547139.USD","LU2236285917.USD","IE0005OL40V9.USD","LU2468319806.SGD","LU0471298777.SGD","NVOX","LU1814569148.SGD","LU0417517546.SGD","LU1983299246.USD","IE00B7KXQ091.USD","IE00BK4W5M84.HKD","IE00BZ1G4Q59.USD","IE0002141913.USD","LU1868836591.USD","SGXZ57979304.SGD","LU0823434740.USD","AGNG","IE00BN29S564.USD","THNR","BK4534","LU2023250330.USD","GB00BDT5M118.USD","LU0345770993.USD","LU0354030511.USD","LU2237438978.USD","LU2111349929.HKD","LU0708995401.HKD","LU2462591350.SGD","LU2361044865.SGD","LU1069344957.HKD","IE00BJT1NW94.SGD","LU2237443549.SGD","LU2237443978.SGD","LU2324357040.USD","LU2491050154.USD","VHT","LLYZ","LU0203202063.USD","LU0466842654.USD","IE00B1XK9C88.USD","IE00BJJMRY28.SGD","LU1989771016.USD","LU1280957306.USD","LU0122379950.USD","LU1988902786.USD","SG9999018865.SGD","LU0225283273.USD","IE00B4R5TH58.HKD","LU0323591593.USD","LU0289739699.SGD","LU1623119135.USD","IE00BJJMRX11.SGD","LU2087625088.SGD","LU2108987350.USD","NVO","NVOC","SGXZ31699556.SGD","SGXZ99366536.SGD","TMED","LU0174119429.USD","NVOH","LU0320765059.SGD","LU0354030438.USD","HRTS","LU1366192091.USD","LU1145028129.USD","LU0889565916.HKD","SG9999014906.USD","LU1551013342.USD","LU2168564065.EUR","LU2213496289.HKD","LU0456855351.SGD","IE00B2B36J28.USD","LU2552382215.SGD","BK4532","LU2461242641.AUD","LU1057294990.SGD","IE0004445015.USD","FTXH","LU0882574139.USD","TRUH","LU0256863811.USD","MEDX","LU2491050071.SGD","LU0823416689.USD","CURE","LU0640476718.USD","LU0198837287.USD","LU2750360641.GBP","XLV","IE00BJJMRZ35.SGD","LU0432979614.USD","LU2462157665.USD","IXJ","IE00BKDWB100.SGD","LU1323610961.USD","IE00B4JS1V06.HKD","LU2089284900.SGD","SG9999015978.USD","IE00BFSS7M15.SGD","IE00BKVL7J92.USD","LU0158827948.USD","JDOC","LU1974910355.USD","LU0820561909.HKD","LU0006306889.USD","LU0079474960.USD","MHIP","LU0320765992.SGD","RXL","SG9999015952.SGD","LU2471134952.CNY","LU0109391861.USD","SG9999014898.SGD","LU1548497426.USD","LU1720051108.HKD","LU2357305700.SGD","LU2063271972.USD","LU0689472784.USD","LU0353189763.USD","LU1804176565.USD","LU1979441026.SGD","LU2168564222.USD","LU2552382058.USD","IE00BK4W5L77.USD","LU2168564495.EUR","LU2756315318.SGD","LU0786609619.USD","LU0471298694.HKD","LU0964807845.USD","LU0882574055.USD","LU0114720955.EUR","LU2089984988.USD","LU2756315664.SGD","LU0672654240.SGD","SG9999014880.SGD","LU1127390331.HKD","LU2168563687.JPY","LU1712237335.SGD","LU1691799644.USD","LU2264538146.SGD","LU0266013472.USD","BK4581","LU0061475181.USD","LU2237443622.USD","LU2750360997.AUD","PPH","BK4007","IE00BKPKM429.USD","LU2023251221.USD","LU2417539215.USD","IE00BFTCPJ56.SGD","ELIL","LU0820561818.USD","LU2089283258.USD","LU1093756325.SGD","BK4533","IE00BWXC8680.SGD","LU1023059063.AUD","LU1035775433.USD","LU1868836914.USD","SG9999015986.USD","LU2271345857.HKD","LU2746668974.SGD","LU0385154629.USD","ILDR","LU0058720904.USD","LU0820562030.AUD","LU0133085943.USD","LU0238689110.USD","IE0001KFT4U8.USD","IE00BJLML261.HKD","LU1868837136.USD","LU2168564149.EUR","BK4588","LU2602419157.SGD","LU2456880835.USD","BK4585","LU0787776722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103503913","title":"异动解读｜诺和诺德盘中下跌5.1%，CagriSema数据未消市场疑虑叠加股东施压并购","url":"https://stock-news.laohu8.com/highlight/detail?id=1103503913","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103503913?lang=zh_cn&edition=full","pubTime":"2026-09-21 21:37","pubTimestamp":1789997826,"startTime":"0","endTime":"0","summary":"9月21日，诺和诺德盘中下跌5.1%，报40.61美元/股，成交额2.35亿美元。消息面上，公司当日举行资本市场日活动并公布CagriSema最新临床数据：头对头试验中减重12.4%优于礼来替尔泊肽的9.1%，另一项试验减重达21%。但市场对该数据反应冷淡，股价不升反降。与此同时，包括Baillie Gifford在内的多家机构股东公开敦促公司通过并购拓展产品线，降低对司美格鲁肽类药物超九成收入的过度依赖。此外，司美格鲁肽被关联罕见致盲眼疾亦加剧市场担忧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德盘中下挫，CagriSema数据难消市场疑虑","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669728150","title":"诺和诺德（NVO）跌4.81% 司美格鲁肽被关联罕见致盲眼疾","url":"https://stock-news.laohu8.com/highlight/detail?id=2669728150","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669728150?lang=zh_cn&edition=full","pubTime":"2026-09-21 19:13","pubTimestamp":1789989235,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德 美股盘前股价承压，最新跌4.81%，报41.15美元。司美格鲁肽是用于2型糖尿病治疗、可辅助减重的处方药，被称作“减肥神药”，近年在全球热销，其潜在副作用持续受到市场关注。该患者服用司美格鲁肽治疗2型糖尿病长达6个月，医生已要求其立刻停药，保护剩余视力。部分医生研究认为，司美格鲁肽或令NAION发病风险提升约一倍；欧洲药品管理局将其列为极罕见副作用，预估万人中最多1例发病。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/MGY3NWNiZjgxNDI5NTMwNTcxNw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MGY3NWNiZjgxNDI5NTMwNTcxNw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306274","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","LU1093756168.USD","BK4532","BK4588","IE00BZ1G4Q59.USD","NVOX","NVOH","BK4599","OZEM","PPH","NVO","NVOC","BK4007","THNR","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669723157","title":"诺和诺德再向礼来“宣战”！CagriSema头对头胜过替尔泊肽，减重12.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669723157","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669723157?lang=zh_cn&edition=full","pubTime":"2026-09-21 19:02","pubTimestamp":1789988564,"startTime":"0","endTime":"0","summary":"诺和诺德公布旗下减重药CagriSema最新临床数据：在与礼来替尔泊肽的直接比较中，CagriSema平均减重12.4%，高于替尔泊肽的9.1%；另一项试验中减重达21%。目前该药已提交FDA审批，预计今年第四季度迎来结果。","market":"nz","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3782221","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德再向礼来“宣战”！CagriSema头对头胜过替尔泊肽，减重12.4%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","NVOX","NVOH","BGIA","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195775815","title":"诺和诺德减重药CagriSema“遇冷”！减重12.4%没能打消市场疑虑","url":"https://stock-news.laohu8.com/highlight/detail?id=1195775815","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195775815?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:12","pubTimestamp":1789978343,"startTime":"0","endTime":"0","summary":"诺和诺德美股盘前短线下跌，现跌超6%；公司计划到2030年将产能扩大至可服务10倍使用口服GLP-1的肥胖患者。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","NVOH","NVOC","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119692963","title":"异动解读｜诺和诺德盘前下跌3.26%，资本市场日在即股东施压要求推进并购","url":"https://stock-news.laohu8.com/highlight/detail?id=1119692963","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119692963?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:09","pubTimestamp":1789978152,"startTime":"0","endTime":"0","summary":"9月21日，诺和诺德盘前下跌3.26%，报41.83美元/股，成交额201.03万美元。消息面上，诺和诺德当日在伦敦举行资本市场日活动，这是新任CEO杜麦克上任后主持的首个投资者日。活动前夕，包括Baillie Gifford在内的多家机构股东公开敦促公司通过并购扩大产品组合，降低对司美格鲁肽类药物的过度依赖。目前诺和诺德超九成销售额来自糖尿病和肥胖症药物，而竞争对手礼来产品线还涵盖肿瘤和神经科学领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德盘前走低，资本市场日股东施压并购","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668900047","title":"诺和诺德股东称公司需通过收购拓展业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2668900047","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668900047?lang=zh_cn&edition=full","pubTime":"2026-09-20 13:28","pubTimestamp":1789882082,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德股东称公司需通过收购拓展业务","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668940474","title":"诺和诺德（NVO）长效生长激素Sogroya®获欧盟CHMP积极意见 拟用于儿科特发性矮小症","url":"https://stock-news.laohu8.com/highlight/detail?id=2668940474","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668940474?lang=zh_cn&edition=full","pubTime":"2026-09-18 18:58","pubTimestamp":1789729104,"startTime":"0","endTime":"0","summary":"特发性矮小症影响全球高达3%的儿童。REAL8III期临床试验数据显示，在第52周时，每周注射一次Sogroya在改善患儿平均年化身高增长速度方面，疗效不劣于每日注射一次的传统生长激素疗法。据介绍，若最终获批，Sogroya将成为欧盟首个且唯一用于治疗特发性矮小症的生长激素疗法。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/YjU2YzAxODc0YzFlOTM1Nzk3MTU1NDIzZDRjODY4MTE1MzM5MTg2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YjU2YzAxODc0YzFlOTM1Nzk3MTU1NDIzZDRjODY4MTE1MzM5MTg2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306223","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","LU1093756325.SGD","LU0154236417.USD","NVOX","OZEM","PPH","THNR","BK4599","BK4007","BK4585","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","NVO","NVOC","BK4588","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182851967","title":"异动解读｜诺和诺德盘中上涨3.07%，联手Orbis达成14亿美元AI新药合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1182851967","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182851967?lang=zh_cn&edition=full","pubTime":"2026-09-17 22:27","pubTimestamp":1789655221,"startTime":"0","endTime":"0","summary":"9月17日，诺和诺德盘中上涨3.07%，报42.99美元/股，成交额1.34亿美元。消息面上，丹麦生物技术公司Orbis Medicines宣布与诺和诺德达成战略合作及许可协议，双方将利用Orbis的AI大环分子发现平台，共同开发针对心血管及代谢类疾病的口服新一代疗法。Orbis有权获得最高14亿美元的资金支持，涵盖预付款、研发及商业化里程碑付款，此外还将获得未来产品销售的分级特许权使用费。诺和诺德还将对Orbis进行战略投资。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德股价上涨，14亿美元押注AI新药","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668964155","title":"诺和诺德（NVO）联手Orbis加码AI新药研发 部署高达14亿美元合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2668964155","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668964155?lang=zh_cn&edition=full","pubTime":"2026-09-17 19:54","pubTimestamp":1789646089,"startTime":"0","endTime":"0","summary":"金吾财讯 | 丹麦生物技术初创公司Orbis Medicine宣布，已与抗糖尿病及减肥药巨头诺和诺德 达成一项总价值最高可达14亿美元的药物研发合作协议，旨在共同开发针对心血管及代谢类疾病的新一代疗法。作为合作的一环，诺和诺德将对Orbis进行战略投资。Orbis有权获得来自诺和诺德最高达14亿美元的资金支持，其中包括预付款、后续潜在的研发与商业化里程碑付款等。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/YjU2YzAxODc0YzFlOTM1Nzk3MTU1NDIzZDRjODY4MTE1MzM5MTg2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YjU2YzAxODc0YzFlOTM1Nzk3MTU1NDIzZDRjODY4MTE1MzM5MTg2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306171","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOC","OZEM","THNR","LU1093756168.USD","BK4532","LU1093756325.SGD","BK4588","LU0154236417.USD","BK4007","NVOH","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","PPH","NVOX","BK4585","NVO","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667598548","title":"诺和诺德（NVO）与Anthropic达成战略合作 将引入Claude模型赋能新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2667598548","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667598548?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:54","pubTimestamp":1789563295,"startTime":"0","endTime":"0","summary":"诺和诺德将引入Anthropic旗下的前沿大模型，应用于新药研发与智能软件工程，以加速创新药物的发现进程。诺和诺德计划率先在特定的研发工作流程中试点测试Claude Science，借此缩短从基础研究到药物上市的周期。Anthropic联合创始人兼CEO Dario Amodei则指出，顶级安全模型的引入有望大幅压缩生物医药突破的时间轴。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/NzFhNTI4MGUwYzI0YmU3ZWQ0MDcxNDc2MTkyOTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NzFhNTI4MGUwYzI0YmU3ZWQ0MDcxNDc2MTkyOTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306114","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","PPH","BK4585","BK4532","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVOX","BK4588","OZEM","IE00BKVL7J92.USD","BK4007","NVO","NVOC","THNR","BK4599","LU0154236417.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novonordisk.com","stockEarnings":[{"period":"1week","weight":-0.1058},{"period":"1month","weight":-0.2063},{"period":"3month","weight":-0.1966},{"period":"6month","weight":0.0716},{"period":"1year","weight":-0.3425},{"period":"ytd","weight":-0.241}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0524},{"period":"6month","weight":0.2099},{"period":"1year","weight":0.1605},{"period":"ytd","weight":0.125}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novo Nordisk A/S成立于1989年，由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球性的医疗保健公司，也是肥胖和糖尿病护理、制造和营销包括GLP-1受体激动剂和现代胰岛素在内的医药产品的世界领先企业。总部位于丹麦，业务遍及约80个国家，产品销往约170个国家。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.120105},{"month":2,"riseRate":0.6,"avgChangeRate":0.019219},{"month":3,"riseRate":0.444444,"avgChangeRate":0.006415},{"month":4,"riseRate":0.622222,"avgChangeRate":0.018023},{"month":5,"riseRate":0.565217,"avgChangeRate":0.019713},{"month":6,"riseRate":0.695652,"avgChangeRate":0.026728},{"month":7,"riseRate":0.478261,"avgChangeRate":-0.002045},{"month":8,"riseRate":0.521739,"avgChangeRate":0.005204},{"month":9,"riseRate":0.543478,"avgChangeRate":-0.006133},{"month":10,"riseRate":0.488889,"avgChangeRate":-0.004606},{"month":11,"riseRate":0.6,"avgChangeRate":0.026574},{"month":12,"riseRate":0.733333,"avgChangeRate":0.048757}],"exchange":"NYSE","name":"诺和诺德","nameEN":"Novo-Nordisk A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺和诺德,NVO,诺和诺德股票,诺和诺德股票老虎,诺和诺德股票老虎国际,诺和诺德行情,诺和诺德股票行情,诺和诺德股价,诺和诺德股市,诺和诺德股票价格,诺和诺德股票交易,诺和诺德股票购买,诺和诺德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}